Pan­dem­ic wait is over: FDA be­gins tran­si­tion to in-per­son meet­ings in March

It’s been al­most three years since any­one has met with FDA staff in per­son at an FDA of­fice. But that’s all about to change as the agency said yes­ter­day that be­gin­ning Feb. 13, CDER and CBER will restart in-per­son, face-to-face in­dus­try meet­ings.

The big caveat: A face-to-face meet­ing with the FDA now in­cludes vir­tu­al meet­ings with cam­eras on, as agreed to in the lat­est user fee deals be­tween the in­dus­try and the FDA.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.